Reports for OCTREOTIDE

Ingredient

OCTREOTIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-01-09 2025-11-06 247309
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166975
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-11 2024-11-08 240046
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-11-28 2025-05-30 244081
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-07-29 2025-08-29 263746
SANDOSTATIN 50MCG SOLUTION Resolved 2022-11-22 2023-02-11 175439
SANDOSTATIN 50MCG SOLUTION Actual shortage 2024-03-22 2024-10-01 223074
SANDOSTATIN 100MCG SOLUTION Resolved 2022-05-06 2023-02-11 160174
SANDOSTATIN 100MCG SOLUTION Actual shortage 2024-02-06 2024-03-21 218624
SANDOSTATIN LAR 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE Resolved 2025-07-14 2025-11-04 262673

Showing 21 to 30 of 32

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OCPHYL 500MCG SOLUTION Reversed 2017-04-10 2017-04-10 6237
SANDOSTATIN 100MCG SOLUTION Discontinued 2024-03-22 2024-03-22 223070
SANDOSTATIN 200MCG SOLUTION Discontinued 2022-02-08 2022-03-07 154429

Showing 1 to 3 of 3